NICE OKs Sarclisa & Mayzent For Funding In England, But Rejects Vindaqel

Scottish HTA Body Greenlights Bavencio, Brineura

 
• By Ian Schofield

The health technology assessment bodies for England and Scotland have this week issued positive recommendations on the funding of several innovative new medicines on the National Health Service, including products for myeloma, kidney cancer and multiple sclerosis.

Close up of diverse young people show thumbs up recommending good quality service, multiethnic clients or customers
NICE and the SMC OKd funding for a range of new therapies this week • Source: Shutterstock

More from United Kingdom

More from Europe